{"number":"US12702739B1","kindCode":"B1","documentType":"grant","title":{"original":"Device and method for administering an anti cancer substance","english":"Device and method for administering an anti cancer substance"},"abstract":{"original":"An anti-cancer substance is administered via the patient's blood ex vivo and in line by establishing a connection between the patient and a device having a chamber containing the anti-cancer substance. The patient's blood in the chamber and the anti-cancer substance interact so that immune cells in the blood (1) are activated to produce an immune response in the patient, or (2) are pre-armed by attaching to the cells antibodies, or (3) both. After activating or pre-arming the cells, the patient's treated blood is returned to the patient.…","english":"An anti-cancer substance is administered via the patient's blood ex vivo and in line by establishing a connection between the patient and a device having a chamber containing the anti-cancer substance. The patient's blood in the chamber and the anti-cancer substance interact so that immune cells in the blood (1) are activated to produce an immune response in the patient, or (2) are pre-armed by attaching to the cells antibodies, or (3) both. After activating or pre-arming the cells, the patient's treated blood is returned to the patient.…"},"applicants":["Individual"],"inventors":["Brian J. Leberthon"],"filingDate":"2021-05-13","publicationDate":"2026-08-11","grantDate":"2026-08-11","verifiedWithOffice":true,"pdfUrl":"https://downloadpatent.com/pdf/US12702739B1.pdf","pages":{"en":"https://downloadpatent.com/patent/US12702739B1","zh-Hant":"https://downloadpatent.com/zh-Hant/patent/US12702739B1","ja":"https://downloadpatent.com/ja/patent/US12702739B1"}}